Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice.
Phase of Trial: Phase IV
Latest Information Update: 05 Feb 2016
At a glance
- Drugs Tocilizumab (Primary) ; Disease-modifying antirheumatics; Tumour necrosis factor alpha inhibitors
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 05 Feb 2016 New trial record